MGTX – meiragtx holdings plc - ordinary shares (US:NASDAQ)
Stock Stats
News
12/16
01:05 pm
mgtx
Low
Latest Published 5 Rare Eye Diseases Market Reports by DelveInsight: Retinitis Pigmentosa, Stargardt Disease, Ocular Melanoma, Uveitis, and Neurotrophic Keratitis [Yahoo! Finance]
12/12
08:52 am
mgtx
Low
Investors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five years [Yahoo! Finance]
12/9
08:00 am
mgtx
Medium
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
11/24
07:27 pm
mgtx
Medium
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
11/18
05:39 pm
mgtx
Medium
MeiraGTx Holdings plc (NASDAQ: MGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $36.00 price target on the stock.
11/13/2024
08:00 am
MGTX
9.2%
MISS
8/12/2024
07:05 am
MGTX
-4.8%
MISS
5/9/2024
08:00 am
MGTX
-0.8%
IN-LINE
11/18
05:39 pm
Reiterates
Buy
Buy
Chardan Capital
Medium
3.3%
11/18
05:04 pm
Maintains
Buy
Buy
Chardan Capital
Medium
3.3%
11/14
11:59 am
Maintains
Outperform
Outperform
RBC Capital
Low
-2.0%
11/14
11:59 am
Maintains
Outperform
Outperform
RBC Capital
Low
-2.0%
12/9
09:15 am
mgtx
Medium
Form 8-K MeiraGTx Holdings plc For: Dec 09
11/13
08:35 am
mgtx
Low
Form 10-Q MeiraGTx Holdings plc For: Sep 30
11/13
08:09 am
mgtx
Medium
Form 8-K MeiraGTx Holdings plc For: Nov 13
11/12
09:41 am
mgtx
Medium
Form SC 13G/A MeiraGTx Holdings plc Filed by: Adage Capital Management, L.P.
10/18
04:48 pm
mgtx
Low
Form SC 13G/A MeiraGTx Holdings plc Filed by: JOHNSON & JOHNSON
Show more
Top News Gainers
5/14 Q1/2019 3/31/2019 EPS -0.620 ZacksConsensus N/A ActVsEst N/A - N/A 20.9%
11/26 MeiraGTx to Present at Upcoming Healthcare Conferences 8.9%
2/1 MeiraGTx Holdings PLC (NASDAQ: MGTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.0%
11/20 Form 4 MeiraGTx Holdings plc For: Nov 19 Filed by: Seligman Nicole 6.9%
12/5 MeiraGTx to Host Parkinson’s Disease R&D Day in New York 6.4%
12/3 Applied Genetics Technology Corporation: Strong Science And Clinical Efficacy [Seeking Alpha] 5.8%
3/2 MeiraGTx Announces Priority Medicines (PRIME) and Advanced Therapy Medicinal Product (ATMP) Designations Granted by the European Medicines Agency to AAV-RPGR Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa 4.4%
9/3 MeiraGTx Holdings PLC (NASDAQ: MGTX) is now covered by analysts at Piper Jaffray Companies. They set an "overweight" rating and a $40.00 price target on the stock. 3.2%
3/26 MeiraGTx Holdings PLC (NASDAQ: MGTX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.0%
1/10 Form 4 MeiraGTx Holdings plc For: Jan 08 Filed by: Naylor Stuart 2.9%
Top News Decliners
3/14 MeiraGTx Holdings PLC (NASDAQ: MGTX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -28.0%
3/11 MeiraGTx Reports Full Year 2019 Financial Results -14.0%
8/7 MeiraGTx Announces Proposed Public Offering of Ordinary Shares -8.0%
3/6 MeiraGTx Holdings PLC (NASDAQ: MGTX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -7.5%
5/29 MeiraGTx Holdings PLC (NASDAQ: MGTX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "sell" rating. -6.6%
1/23 Form 4 MeiraGTx Holdings plc For: Jan 21 Filed by: Giroux Richard -4.5%
2/14 Form SC 13G/A MeiraGTx Holdings plc Filed by: Kadmon Holdings, Inc. -4.3%
5/10 Form 8-K MeiraGTx Holdings plc For: May 09 -3.1%
3/3 MeiraGTx Holdings PLC (NASDAQ: MGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $45.00 price target on the stock. -3.0%
2/24 MeiraGTx to Present at Upcoming Investor Conferences -2.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3